Pregnancy Labeling: FDA Should Follow EMEA’s Lead On Classification, Firms Say

FDA should adopt the European Medicines Agency's categorizations of pregnancy risk information in labeling, industry recommends in comments on the agency's proposed rule

More from Archive

More from Pink Sheet